SEC Company Response from PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Jan 5, 2018
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Jan. 5, 2018 · CIK: 0001624326 · Accession: 0001493152-18-000202
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-221406
Letter
Re: PAVmed Inc.
PAVMED INC.
One Grand Central Place, Suite 4600
New York, New York 10165
January 4, 2018
Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Registration Statement on Form S-3
Originally Filed November 8, 2017
File No. 333-221406
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. (the “Company”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement (File No. 333-221406), so that such Registration Statement will become effective at 4:30 p.m. Eastern Time on Monday, January 8, 2018, or as soon thereafter as practicable.
Sincerely,
PAVMED
INC.
Show Raw Text
CORRESP
1
filename1.htm
PAVMED
INC.
One
Grand Central Place, Suite 4600
New
York, New York 10165
January
4, 2018
Securities
and Exchange Commission
Division
of Corporation Finance
Washington,
DC 20549
Re:
PAVmed
Inc.
Registration
Statement on Form S-3
Originally
Filed November 8, 2017
File
No. 333-221406
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. (the “Company”) hereby requests
acceleration of the effectiveness of the above-referenced Registration Statement (File No. 333-221406), so that such Registration
Statement will become effective at 4:30 p.m. Eastern Time on Monday, January 8, 2018, or as soon thereafter as practicable.
Sincerely,
PAVMED
INC.
By:
/s/
Lishan Aklog, M.D.
Name:
Lishan
Aklog, M.D.
Title:
Chairman
and Chief Executive Officer